Medicines for quick relief of the narrowed bronchial tubes caused by asthma include short-acting beta2-agonists. These medicines relieve sudden increases of symptoms (asthma attacks) quickly. But overuse may be harmful.
Overuse of short-acting beta2-agonists has been associated with worsening asthma and increased risk of death.1 People who have severe asthma usually are the ones at greatest risk for illness and death from asthma. They may be taking higher doses of short-acting beta2-agonists to control their symptoms instead of increasing the use of anti-inflammatory medicine such as inhaled corticosteroids.
People who overuse short-acting beta2-agonists may feel their asthma is under control when, in fact, inflammation in the airways is becoming worse, putting them in danger of a severe, life-threatening attack (status asthmaticus).
In general, you may need more long-term treatment if you are using short-acting beta2-agonists on more than 2 days a week (except before exercise). Talk to your doctor if you are using your quick-relief medicine this often. Frequent use of quick-relief medicines may mean that your symptoms and inflammation are not well controlled.
|Primary Medical Reviewer||E. Gregory Thompson, MD - Internal Medicine|
|Primary Medical Reviewer||Brian D. O'Brien, MD - Internal Medicine|
|Specialist Medical Reviewer||Lora J. Stewart, MD, MPH - Allergy and Immunology, Pediatrics|
|Last Revised||May 11, 2011|
Last Revised: April 11, 2012
This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information.